Catalog/Growth
Growth
AOD-9604
hGH fragment 176–191
A modified C-terminal fragment of hGH investigated for lipolytic activity without somatropin’s growth-promoting effects.
Sequence
- Hydrophobic
- Polar
- Charged
C-terminal fragment of human growth hormone with a disulfide
YLRIVQCRSVEGSCGF
- CAS
- 221231-10-3
- Formula
- C78H123N23O23S2
- Mass (g/mol)
- 1815.08
- Half-life
- ~30 min
- Form
- Lyophilized acetate
- Purity
- ≥98% HPLC
Mechanism
Designed to isolate the fat-metabolism region of hGH. Does not bind the GH receptor as intact hormone does.
Research notes
Clinical development did not yield an approved drug. Useful as a domain-excision teaching sequence.
Lyophilized frozen. Protect the disulfide.
Typical reconstitution
Catalog convenience numbers — not a protocol. Vial 10 mg in 2 mL; default draw 250 mcg.